Hepatitis, Animal: Clinical Trials

19 trials for Hepatitis, Animal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 recruiting, 2 active not recruiting, 2 not yet recruiting. 5 Phase 2, 2 Not applicable, 2 Phase 1, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Active not recruiting 1, Recruiting 1
Not applicable2Not yet recruiting 1, Terminated 1
Phase 12Active not recruiting 1, Completed 1
Early Phase 11Completed 1
Phase 31Unknown 1

Follow Hepatitis, Animal: new trials by email Literature Review of Hepatitis, Animal trials Research Report on Hepatitis, Animal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Characterization of Peri-Hemorrhagic Cerebral Edema Using Synthetic Sodium Imaging With 7-Tesla and 3-Tesla MRI
Sodium tissue concentration will be measured in perihematomal oedema - Intracerebral Haemorrhage, ICH
Not applicableNot yet recruitingUniversity Hospital, Lille482026-09-012026-09-01
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)
ChAdOx1 RVF, Rabies Vaccine - Rift Valley Fever
Phase 2Active not recruitingUniversity of Oxford2402025-07-082025-11-17
Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011
IDB-011 dose level 1, IDB-011 dose level 2, IDB-011 dose level 3 - Rift Valley Fever
Phase 1Active not recruitingIDBiologics, Inc.402025-04-022026-03-25
RVF and Other Emerging Infectious Diseases in East and Central Africa
Evidence of past or recent RVF exposure - Rift Valley Fever, Hemorrhagic Fevers, Viral
RecruitingWashington State University50002025-02-012026-10-05
Epidemiology of Intracerebral Hemorrhage
ICH - Intracerebral Hemorrhage
Not yet recruitingAssiut University602024-11-302024-10-23
A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults
ChAdOx1 RVF, Saline - RVF, Rift Valley Fever
Phase 1CompletedUniversity of Oxford302022-05-312023-02-06
Non-Invasive Monitoring of Traumatic Brain Injury Progression Using the Infrascanner (MOBI-1)
Standard care plus infrascans - Brain Injuries, Traumatic
CompletedUniversity of Alabama at Birmingham3992022-04-182025-09-02
Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)
ChAdOx1 RVF - Rift Valley Fever
Early Phase 1CompletedUniversity of Oxford152021-06-112023-05-19
Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
RVF Vaccine - Rift Valley Fever
Phase 2RecruitingU.S. Army Medical Research and Development Command5002018-10-042021-02-11
Proper Timing of Control of Hypertension and Outcome in Acute Spontaneous Intracerebral Hemorrhage.
Modified Rankin Scale (mRS) - Intra Cerebral Hemorrhage, Hypertension
CompletedMansoura University Hospital1502018-05-012019-12-03
Tolvaptan for Patients With Acute Neurological Injuries
Tolvaptan - Hyponatremia, SIADH
Not applicableTerminatedPolderman, Kees, H., MD, PhD252015-08-012018-09-24
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
Intracerebral Hemorrhage
CompletedOSF Healthcare System22013-09-012016-05-19
Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia
Cincinnati Sub-Zero," Blanketrol III" - Hypothermia, Primary Intracerebral Hemorrhage
Phase 3UnknownUniversity of Rijeka202011-01-012010-12-28
Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
Inactivated, Dried (TSI-GSD 200), RVF Vaccine - Rift Valley Fever
Phase 2CompletedU.S. Army Medical Research and Development Command982009-09-012022-03-04
Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine
RVF MP-12 - Rift Valley Fever
Phase 2CompletedU.S. Army Medical Research and Development Command202006-08-012020-01-03
Rift Valley Fever in Kenya
Rift Valley Fever
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2502006-03-012010-08-27
Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH
Nicardipine and Nipride - Subarachnoid Hemorrhage, Intracerebral Hemorrhage
CompletedUniversity of Illinois at Chicago1632004-06-012007-06-22
Safety and Immunogenicity Study of Rift Valley Fever Vaccine
TSI-GSD 200 RVF Vaccine - Rift Valley Fever
Phase 2CompletedU.S. Army Medical Research and Development Command2782004-06-012020-01-03

Narrower conditions

Rift Valley Fever (11)  ·  Hepatitis, Infectious Canine (8)  ·  Cerebral Hemorrhage (5)  ·  Hemorrhagic Fevers, Viral (3)  ·  Stroke (3)  ·  Arbovirus Infections (2)  ·  Nervous System Diseases (2)  ·  Virus Diseases (2)  ·  Adenoviridae Infections (1)  ·  Arenaviridae Infections (1)  ·  Brain Injuries, Traumatic (1)  ·  Brucellosis (1)  ·  Bunyaviridae Infections (1)  ·  Caliciviridae Infections (1)  ·  Chickenpox (1)

Broader conditions

Animal Diseases (19)  ·  Digestive System Diseases (19)  ·  Hepatitis (19)  ·  Hepatitis, Viral, Animal (19)  ·  Infections (19)  ·  Liver Diseases (19)  ·  Virus Diseases (17)  ·  Mosquito-Borne Diseases (11)  ·  RNA Virus Infections (11)  ·  Bunyaviridae Infections (10)  ·  Vector Borne Diseases (10)  ·  Arbovirus Infections (9)  ·  DNA Virus Infections (9)  ·  Adenoviridae Infections (8)

Interventions

Desiccation (1)  ·  Immunoglobulin M (1)  ·  Nicardipine (1)  ·  Nitroprusside (1)  ·  Rabies Vaccines (1)  ·  Sodium Chloride (1)  ·  Tolvaptan (1)

Sponsors

U.S. Army Medical Research and Development Command (4)  ·  University of Oxford (3)  ·  Assiut University (1)  ·  IDBiologics, Inc. (1)  ·  Institut Pasteur du Cambodge (1)  ·  Mansoura University Hospital (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  OSF Healthcare System (1)  ·  Polderman, Kees, H., MD, PhD (1)  ·  University Hospital, Lille (1)  ·  University of Alabama at Birmingham (1)  ·  University of Illinois at Chicago (1)  ·  University of Rijeka (1)  ·  Washington State University (1)

Countries

United States (9)  ·  Kenya (3)  ·  Uganda (2)  ·  Cambodia (1)  ·  Croatia (1)  ·  Democratic Republic of the Congo (1)  ·  Egypt (1)  ·  Tanzania (1)  ·  United Kingdom (1)

Top investigators

Adrian VS Hill, Prof (1)  ·  Ahmed NasrEldein, Ass.Professor (1)  ·  Andrew Tsung, M.D. (1)  ·  Ben Z Roitberg, MD (1)  ·  Claude Flamand, Ph.D. (1)  ·  Esmael M Ahmed, MD (1)  ·  Igor Antoncic, MD, MSc (1)  ·  Jan O Jansen, MBBS, PhD (1)  ·  Janice Rusnak, MD (1)  ·  Kees Polderman, MD, PhD (1)  ·  M. Kariuki Njenga, PhD (1)  ·  Norhan MH Bakri, MD (1)  ·  Phillip Pittman, MD (1)  ·  Pontiano Kaleebu, PhD (1)  ·  Ronald Reisler, MD (1)

Results publications

PMID 28178408, PMID 30319113, PMID 37060917, PMID 41237791, PMID 41652539

NIH funding

U01AI151799 (1)